Sakakibara Shan Riku 4
4 · BillionToOne, Inc. · Filed Jun 26, 2026
Research Summary
AI-generated summary of this filing
BillionToOne (BLLN) CPO Sakakibara Exercises Options, Sells Shares
What Happened Sakakibara Shan Riku, Chief Product Officer of BillionToOne, exercised option-related derivatives and sold shares on June 24, 2026. The filing shows two option-related transactions of 4,000 shares each at an exercise price of $8.65 per share (reported amounts $34,600 each). Separately, Sakakibara sold two blocks of 4,000 shares in open-market transactions at $110.00 per share, generating gross proceeds of $440,000 each (total $880,000). The transactions were reported on a Form 4 filed June 26, 2026.
Key Details
- Transaction date: 2026-06-24 (reported 2026-06-26 — timely filing).
- Option exercise entries: 4,000 shares @ $8.65 (acquired) = $34,600; 4,000 shares @ $8.65 (derivative disposition) = $34,600.
- Open-market sales: 4,000 shares @ $110.00 = $440,000 (two separate sales; total $880,000).
- Footnotes: Transactions were executed under a Rule 10b5-1 trading plan adopted March 6, 2026 (F1). Options are fully vested and exercisable; underlying grant details referenced in the Form 3 filed Nov 5, 2025 (F2).
- Shares owned after the transactions: not specified in the provided summary — see the full Form 4 for post-transaction holdings.
Context
- Code M entries denote option exercises. The combination of exercise entries and same-day open-market sales indicates the exercised shares were sold the same day (a common cashless or immediate-sale pattern), but the filing should be consulted for exact mechanics.
- The trades were executed under a pre-established 10b5-1 plan, which often governs scheduled insider sales and reduces the implication that sales reflect a change in sentiment. The reporting person is an officer (CPO); this is not presented as a 10% owner transaction.
Insider Transaction Report
Form 4
Sakakibara Shan Riku
Chief Product Officer
Transactions
- Exercise/Conversion
Class A Common Stock
2026-06-24$8.65/sh+4,000$34,600→ 216,000 total - Sale
Class A Common Stock
[F1]2026-06-24$110.00/sh−4,000$440,000→ 212,000 total - Sale
Class A Common Stock
[F1]2026-06-24$110.00/sh−4,000$440,000→ 208,000 total - Exercise/Conversion
Stock Option (right to buy)
[F2]2026-06-24$8.65/sh−4,000$34,600→ 36,000 totalExercise: $8.65Exp: 2033-01-18→ Class A Common Stock (4,000 underlying)
Footnotes (2)
- [F1]The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2026.
- [F2]The options are fully vested and exercisable. The terms of the underlying option grant are as previously reported on the Reporting Person's Form 3 filed on November 5, 2025.
Signature
/s/ Thomas P. Lynch, Attorney-in-Fact|2026-06-26